US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

OPUS GENETICS INC

1.27

-0.0100-0.78%

Post-market: 1.270.00000.00%19:05 EDT

Volume:129.82K

Turnover:163.34K

Market Cap:76.08M

PE:-0.84

High:1.28

Open:1.28

Low:1.24

Close:1.28

52wk High:1.75

52wk Low:0.6500

Shares:59.91M

Float Shares:30.28M

Volume Ratio:0.44

T/O Rate:0.43%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.5143

EPS(LYR):-2.1535

ROE:-200.57%

ROA:-55.20%

PB:4.35

PE(LYR):-0.59

Loading ...

Overview Company News Filings

Company Profile

Company Name:

OPUS GENETICS INC

Exchange:

NASDAQ

Establishment Date:

2018

Employees:

18

Office Location:

8 Davis Drive,Suite 220,Durham,North Carolina,United States

Website:

http://www.ocuphire.com

Zip Code:

27709

Phone:

Fax:

- -

Introduction:

Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. The company offers Phentolamine Ophthalmic Solution for reversal of mydriasis, as well as is in Phase III clinical trials for presbyopia and dim light or night vision disturbances. Its lead retinal product candidate is APX3330, a small-molecule inhibitor of reduction oxidation effector factor-1 protein that has completed Phase II clinical trial for the treatment of diabetic retinopathy. The company also develops APX2009 and APX2014 that are preclinical product candidates for retina indications. The company was formerly known as Ocuphire Pharma, Inc. Opus Genetics, Inc. was founded in 2018 and is headquartered in Farmington Hills, Michigan.

Directors

Name

Position

Cam Gallagher

Independent Chairman of the Board and Director

George Magrath

Chief Executive Officer, Director

James S. Manuso

Independent Director

Sean Ainsworth

Independent Director

Susan K. Benton

Independent Director

Adrienne Graves

Director

Benjamin R. Yerxa

Director

Jean Bennett

Director

Richard J. Rodgers

Director

Shareholders

Name

Position

George Magrath

Chief Executive Officer, Director

Joseph Schachle

Chief Operating Officer

Amy Rabourn

Senior Vice President of Finance

Bernhard Hoffmann

Senior Vice President of Corporate Development

Robert Gagnon

Chief Financial Officer and Principal Accounting Officer

Ash Jayagopal

Chief Scientific and Development Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IRD/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IRD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IRD\",,,,,undefined,":{"symbol":"IRD","market":"US","secType":"STK","nameCN":"OPUS GENETICS INC","latestPrice":1.27,"timestamp":1757102400000,"preClose":1.28,"halted":0,"volume":129817,"hourTrading":{"tag":"盘后","latestPrice":1.27,"preClose":1.27,"latestTime":"19:05 EDT","volume":267,"amount":339.38,"timestamp":1757113527444},"delay":0,"floatShares":30281341,"shares":59908055,"eps":-1.514273,"marketStatus":"Market Closed","change":-0.01,"latestTime":"09-05 16:00:00 EDT","open":1.28,"high":1.28,"low":1.24,"amount":163344.7907,"amplitude":0.03125,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.514273,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1757318400000},"marketStatusCode":7,"adr":0,"listingDate":1100235600000,"exchange":"NASDAQ","adjPreClose":1.28,"preHourTrading":{"tag":"盘前","latestPrice":1.2501,"preClose":1.28,"latestTime":"09:26 EDT","volume":160,"amount":199.075696,"timestamp":1757078790959},"postHourTrading":{"tag":"盘后","latestPrice":1.27,"preClose":1.27,"latestTime":"19:05 EDT","volume":267,"amount":339.38,"timestamp":1757113527444},"volumeRatio":0.44096408077467014,"impliedVol":0.9026,"impliedVolPercentile":0.6667},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IRD\",,,,,undefined,":{"symbol":"IRD","floatShares":30281341,"roa":"-55.20%","roe":"-200.57%","lyrEps":-2.153504,"volumeRatio":0.44096408077467014,"shares":59908055,"dividePrice":0,"high":1.28,"amplitude":0.03125,"preClose":1.28,"low":1.24,"week52Low":0.65,"pbRate":"4.35","psRate":"4.93","week52High":1.75,"institutionHeld":0,"latestPrice":1.27,"eps":-1.514273,"divideRate":0,"volume":129817,"delay":0,"ttmEps":-1.514273,"open":1.28,"prevYearClose":1.19,"prevWeekClose":1.22,"prevMonthClose":1.22,"prevQuarterClose":0.9421,"fiveDayClose":1.19,"twentyDayClose":1.09,"sixtyDayClose":1.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IRD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-13","symbol":"IRD","fiscalQuarterEnding":"2025/06","expectedEps":-0.25,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.12},{"market":"US","date":"2025-05-15","symbol":"IRD","fiscalQuarterEnding":"2025/03","expectedEps":-0.34,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.32},{"market":"US","date":"2025-03-31","symbol":"IRD","fiscalQuarterEnding":"2024/12","expectedEps":-0.34,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"pre","actualEps":-1.27},{"market":"US","date":"2024-11-12","symbol":"IRD","fiscalQuarterEnding":"2024/09","expectedEps":-0.3,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.29},{"market":"US","date":"2024-08-13","symbol":"IRD","fiscalQuarterEnding":"2024/06","expectedEps":-0.29,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":-0.3}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IRD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IRD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1750219200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IRD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IRD","date":"2025-09-05","current":-1.384803,"percent":0.146226,"low":-2.964142,"twenty":-1.335088,"median":-1.160946,"eighty":-0.797415,"high":-0.560128,"avg":-1.196044,"sd":0.429084,"marketCap":80699383},"quantilePoints":[{"date":"2024-10-31","current":-2.785848,"twenty":-2.857166,"median":-2.64666,"eighty":-2.37374,"marketCap":39294383},{"date":"2024-11-08","current":-2.429259,"twenty":-2.692243,"median":-2.607554,"eighty":-2.476187,"marketCap":34264702},{"date":"2024-11-15","current":-1.225421,"twenty":-2.616468,"median":-2.568551,"eighty":-2.326813,"marketCap":33321637},{"date":"2024-11-22","current":-1.142487,"twenty":-2.607554,"median":-2.49612,"eighty":-1.192247,"marketCap":31066518},{"date":"2024-11-29","current":-1.288651,"twenty":-2.607554,"median":-2.173143,"eighty":-1.193702,"marketCap":35040987},{"date":"2024-12-06","current":-1.323479,"twenty":-2.603096,"median":-1.364112,"eighty":-1.225421,"marketCap":35988040},{"date":"2024-12-13","current":-1.288651,"twenty":-2.574123,"median":-1.335088,"eighty":-1.234669,"marketCap":35040987},{"date":"2024-12-20","current":-1.14597,"twenty":-2.527405,"median":-1.303163,"eighty":-1.16559,"marketCap":31161223},{"date":"2024-12-27","current":-1.253822,"twenty":-2.505202,"median":-1.288651,"eighty":-1.163268,"marketCap":34093933},{"date":"2025-01-03","current":-1.462793,"twenty":-2.49612,"median":-1.294455,"eighty":-1.172556,"marketCap":39776255},{"date":"2025-01-10","current":-1.683372,"twenty":-2.442631,"median":-1.320577,"eighty":-1.181843,"marketCap":45774262},{"date":"2025-01-17","current":-1.346698,"twenty":-2.224366,"median":-1.346698,"eighty":-1.20274,"marketCap":36619410},{"date":"2025-01-24","current":-1.335088,"twenty":-1.87928,"median":-1.335088,"eighty":-1.207384,"marketCap":36303725},{"date":"2025-01-31","current":-1.288651,"twenty":-1.676407,"median":-1.329284,"eighty":-1.218206,"marketCap":35040987},{"date":"2025-02-07","current":-1.416355,"twenty":-1.657832,"median":-1.323479,"eighty":-1.225421,"marketCap":38513517},{"date":"2025-02-14","current":-1.335088,"twenty":-1.648544,"median":-1.323479,"eighty":-1.239294,"marketCap":36303725},{"date":"2025-02-21","current":-1.288651,"twenty":-1.616038,"median":-1.323479,"eighty":-1.250654,"marketCap":35040987},{"date":"2025-02-28","current":-1.207384,"twenty":-1.525484,"median":-1.317674,"eighty":-1.232138,"marketCap":32831195},{"date":"2025-03-07","current":-1.160946,"twenty":-1.444218,"median":-1.31187,"eighty":-1.207384,"marketCap":31568457},{"date":"2025-03-14","current":-1.07968,"twenty":-1.411711,"median":-1.30026,"eighty":-1.1772,"marketCap":29358665},{"date":"2025-03-21","current":-1.335088,"twenty":-1.404745,"median":-1.30026,"eighty":-1.16559,"marketCap":36303725},{"date":"2025-03-28","current":-1.637559,"twenty":-1.525484,"median":-1.31187,"eighty":-1.1772,"marketCap":44528506},{"date":"2025-04-04","current":-0.76585,"twenty":-1.525484,"median":-1.306065,"eighty":-1.160946,"marketCap":44060874},{"date":"2025-04-11","current":-0.564318,"twenty":-1.462793,"median":-1.288651,"eighty":-1.14388,"marketCap":32466352},{"date":"2025-04-17","current":-0.581158,"twenty":-1.453505,"median":-1.288651,"eighty":-1.129154,"marketCap":33435158},{"date":"2025-04-25","current":-0.632466,"twenty":-1.414033,"median":-1.288651,"eighty":-1.081468,"marketCap":36387058},{"date":"2025-05-02","current":-0.741567,"twenty":-1.404745,"median":-1.288651,"eighty":-1.054291,"marketCap":42663825},{"date":"2025-05-09","current":-0.787263,"twenty":-1.404745,"median":-1.277041,"eighty":-0.791089,"marketCap":45292790},{"date":"2025-05-16","current":-0.737114,"twenty":-1.402423,"median":-1.253822,"eighty":-0.755291,"marketCap":43209631},{"date":"2025-05-23","current":-0.783669,"twenty":-1.393136,"median":-1.253822,"eighty":-0.759832,"marketCap":45938661},{"date":"2025-05-30","current":-0.771642,"twenty":-1.393136,"median":-1.251182,"eighty":-0.76585,"marketCap":45233661},{"date":"2025-06-06","current":-1.017762,"twenty":-1.393136,"median":-1.225421,"eighty":-0.767335,"marketCap":59661197},{"date":"2025-06-13","current":-1.009213,"twenty":-1.381526,"median":-1.207384,"eighty":-0.771254,"marketCap":59160042},{"date":"2025-06-20","current":-0.947842,"twenty":-1.372239,"median":-1.207384,"eighty":-0.771564,"marketCap":55562472},{"date":"2025-06-27","current":-1.038117,"twenty":-1.360629,"median":-1.184165,"eighty":-0.771642,"marketCap":60854420},{"date":"2025-07-03","current":-1.017762,"twenty":-1.358307,"median":-1.160946,"eighty":-0.77653,"marketCap":59661197},{"date":"2025-07-11","current":-1.139893,"twenty":-1.351342,"median":-1.160017,"eighty":-0.782117,"marketCap":66820540},{"date":"2025-07-18","current":-1.185692,"twenty":-1.346698,"median":-1.152239,"eighty":-0.783669,"marketCap":69505294},{"date":"2025-07-25","current":-1.231492,"twenty":-1.339732,"median":-1.160017,"eighty":-0.783669,"marketCap":72190048},{"date":"2025-08-01","current":-1.129716,"twenty":-1.335088,"median":-1.160248,"eighty":-0.785825,"marketCap":66223928},{"date":"2025-08-08","current":-1.10936,"twenty":-1.335088,"median":-1.151155,"eighty":-0.789762,"marketCap":65030704},{"date":"2025-08-15","current":-1.213067,"twenty":-1.335088,"median":-1.150071,"eighty":-0.791428,"marketCap":70691504},{"date":"2025-08-22","current":-1.177087,"twenty":-1.335088,"median":-1.151155,"eighty":-0.791428,"marketCap":68594722},{"date":"2025-08-29","current":-1.287434,"twenty":-1.335088,"median":-1.160248,"eighty":-0.791428,"marketCap":75025207},{"date":"2025-09-05","current":-1.384803,"twenty":-1.335088,"median":-1.160946,"eighty":-0.797415,"marketCap":80699383}],"updateTime":1757189286853},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":560534013,"yearFounded":2018,"employeeNum":18,"address":"8 Davis Drive,Suite 220,Durham,North Carolina,United States","zipCode":"27709","officePhone":"984 884 6030"},"stockCompanyDetail":{"websiteUrl":"http://www.ocuphire.com","stockEarnings":[{"period":"1week","weight":0.0756},{"period":"1month","weight":0.1532},{"period":"3month","weight":0.2308},{"period":"6month","weight":0.2821},{"period":"1year","weight":0.0579},{"period":"ytd","weight":0.0756}],"compareEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":0.0337},{"period":"3month","weight":0.0834},{"period":"6month","weight":0.1271},{"period":"1year","weight":0.1782},{"period":"ytd","weight":0.1076}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. The company offers Phentolamine Ophthalmic Solution for reversal of mydriasis, as well as is in Phase III clinical trials for presbyopia and dim light or night vision disturbances. Its lead retinal product candidate is APX3330, a small-molecule inhibitor of reduction oxidation effector factor-1 protein that has completed Phase II clinical trial for the treatment of diabetic retinopathy. The company also develops APX2009 and APX2014 that are preclinical product candidates for retina indications. The company was formerly known as Ocuphire Pharma, Inc. Opus Genetics, Inc. was founded in 2018 and is headquartered in Farmington Hills, Michigan.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.074201},{"month":2,"riseRate":0.47619,"avgChangeRate":0.057078},{"month":3,"riseRate":0.333333,"avgChangeRate":0.005763},{"month":4,"riseRate":0.4,"avgChangeRate":0.517227},{"month":5,"riseRate":0.619048,"avgChangeRate":4.359031},{"month":6,"riseRate":0.380952,"avgChangeRate":-0.018759},{"month":7,"riseRate":0.380952,"avgChangeRate":0.005385},{"month":8,"riseRate":0.380952,"avgChangeRate":-0.018628},{"month":9,"riseRate":0.47619,"avgChangeRate":-0.019553},{"month":10,"riseRate":0.25,"avgChangeRate":-0.106096},{"month":11,"riseRate":0.3,"avgChangeRate":-0.065242},{"month":12,"riseRate":0.47619,"avgChangeRate":0.059596}],"exchange":"NASDAQ","name":"OPUS GENETICS INC","nameEN":"OPUS GENETICS INC"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"IRD\",market:\"US\",,,undefined,":{"directors":[{"name":"Cam Gallagher","position":"Independent Chairman of the Board and Director"},{"name":"George Magrath","position":"Chief Executive Officer, Director"},{"name":"James S. Manuso","position":"Independent Director"},{"name":"Sean Ainsworth","position":"Independent Director"},{"name":"Susan K. Benton","position":"Independent Director"},{"name":"Adrienne Graves","position":"Director"},{"name":"Benjamin R. Yerxa","position":"Director"},{"name":"Jean Bennett","position":"Director"},{"name":"Richard J. Rodgers","position":"Director"}],"executives":[{"name":"George Magrath","position":"Chief Executive Officer, Director"},{"name":"Joseph Schachle","position":"Chief Operating Officer"},{"name":"Amy Rabourn","position":"Senior Vice President of Finance"},{"name":"Bernhard Hoffmann","position":"Senior Vice President of Corporate Development"},{"name":"Robert Gagnon","position":"Chief Financial Officer and Principal Accounting Officer"},{"name":"Ash Jayagopal","position":"Chief Scientific and Development Officer"}]}}}